ARWR - Arrowhead Pharmaceuticals Inc. (ARWR) CEO Christopher Anzalone on Q4 2021 Results - Earnings Call Transcript
Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2021 Earnings Conference Call November 22, 2021, 04:30 PM ET Company Participants Vince Anzalone - VP, IR Christopher Anzalone - President and CEO Javier San Martin - Chief Medical Officer Ken Myszkowski - CFO James Hamilton - SVP, Discovery and Translational Medicine Conference Call Participants Luca Issi - RBC Capital Alethia Young - Cantor Maury Raycroft - Jefferies Esther Rajavelu - UBS Joel Beatty - Baird Patrick Trucchio - H.C. Wainwright Mani Foroohar - SVB Leerink Mayank Mamtani - B. Riley Securities Presentation Operator Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode. After the presentation, there will be an opportunity to ask questions. I will now hand the conference call over to Vince Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead. Vince Anzalone Good afternoon, everyone. Thank you
For further details see:
Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q4 2021 Results - Earnings Call Transcript